Cormorant Asset Management, LP

Holdings History for BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG)

Symbol: DRUG on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 1,059,331 shares
Security Ownership %: 11%

Shares, Excluding Options vs Price

Value, Excluding Options

Cormorant Asset Management, LP ownership in BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG)

06 Feb 2026 - Cormorant Asset Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,059,331 shares of BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG). This represents 11% ownership of the company. This is the first filing by Cormorant Asset Management, LP disclosing ownership of BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Cormorant Asset Management, LP	11%		$82,670,191	1,059,331			$78.04	13G/A	31 Jan 2026	06 Feb 2026, 15:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	4.7%	0%	$82,670,191	1,059,331	0		$78.04	Q4 2025
30 Sep 2025	4.4%	0%	$64,259,018	1,059,331	0		$60.66	Q3 2025
30 Jun 2025	2.1%	0%	$27,659,132	1,059,331	0		$26.11	Q2 2025
31 Mar 2025	2.9%	0%	$38,210,069	1,059,331	0		$36.07	Q1 2025
31 Dec 2024	2.1%	+2.1%	$38,157,103	1,059,331	+1,059,331	NEW	$36.02	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.